AT7519M

· Astex Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AT7519M, covering 2023-08-04 to 2024-08-02. Get the full timeline:

Most recent: Clinical Trial Update: Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma [Phase 1, Phase 2]

See pricing